ENDRA Life Sciences Inc. Cash Flow Statement

Cash Flow Statement Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -2.78M-5.38M-9.80M-13.31M-11.73M-11.23M-13.18M-10.06M-11.51M
Depreciation and Depletion 0.06M0.06M0.07M0.08M0.10M0.12M0.10M0.12M0.05M
Share-based Compensation 0.23M1.00M1.37M1.40M2.10M1.44M1.20M1.00M0.57M
Gains from Investment Securities 3.57M0.51M
Asset Writedowns and Impairment 0.29M0.25M
Cash from Operations -1.32M-3.30M-7.70M-8.59M-10.75M-11.12M-12.77M-9.55M-7.40M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.71M0.03M0.34M0.64M0.14M0.15M0.16M
Amortization of Deferred Charges 0.90M0.71M0.73M2.36M0.23M
Depreciation & Amortization (CF) 0.06M0.06M0.07M0.08M0.10M0.12M0.10M0.12M0.05M
Change in Working Capital
Change in Receivables 0.01M-0.01M
Change in Inventory -0.06M0.15M0.16M0.05M0.48M0.69M1.36M0.12M-0.24M
Change in Accured Expenses 0.20M0.53M0.13M0.76M-0.83M0.49M0.11M-0.82M-0.20M
Other Working Capital Changes 0.00M0.07M0.26M0.11M0.27M0.96M-0.36M-0.17M-0.26M
Investing Activities
Capital Expenditures 0.01M0.10M0.04M0.08M0.04M0.20M0.03M0.02M
Sales of Property, Plant and Equipment 0.01M0.00M
Cash from Investing Activities -0.01M-0.10M-0.04M-0.08M-0.04M-0.20M-0.02M-0.01M
Financing Activities
Other financing activities 0.06M0.03M0.26M
Cash from Financing Activities 1.44M8.77M8.67M8.34M11.88M13.40M8.40M7.52M7.81M
Dividend Payments
Dividends Paid - Common 4.22M0.40M0.12M
Additional items
Change in Cash 0.13M5.46M0.87M-0.30M1.05M2.23M-4.57M-2.06M0.40M
Free Cash Flow -1.32M-3.31M-7.80M-8.63M-10.82M-11.17M-12.97M-9.58M-7.42M
Net Cash Flow 0.13M5.46M0.87M-0.30M1.05M2.23M-4.57M-2.06M0.40M